Roche's Genentech has settled a US lawsuit against Indian biopharmaceutical company Biocon over its ​proposed biosimilar of Genentech's blockbuster breast-cancer drug ‌Perjeta, Biocon said Wednesday.

Log in or sign up to comment.

No comments yet.

← Back to stories

Create FREE account

or login to continue

Signup with GoogleSignup with GitHubSignup with BlueskySignup with Blacksky
Sign up with email

Already have an account? Log in